Frankfurt, Germany

Wolfgang Stille

This inventor holds 1 USPTO granted patent. Top assignee: Thera Patent Gmbh & Co. Kg. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wolfgang Stille: Innovator in Implantable Active Substance Depot Materials

Introduction

Wolfgang Stille is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of medical technology, particularly in the development of implantable active substance depot materials. His innovative work has the potential to enhance therapeutic outcomes for patients requiring sustained drug delivery.

Latest Patents

Stille holds a patent for an "Implantable active substance depot material." This invention comprises a glass ionomer cement combined with one or more chemotherapeutic agents. The design of this active substance depot ensures an initially high release rate of the active substance, followed by a gradual discharge in small doses until the complete depletion of the deposited active substance occurs. This innovative approach aims to improve the efficacy of drug delivery systems in medical applications.

Career Highlights

Wolfgang Stille is associated with Thera Patent GmbH & Co. KG, where he continues to advance his research and development efforts. His work in this company reflects his commitment to improving medical technologies and patient care through innovative solutions.

Collaborations

Stille collaborates with talented professionals in his field, including Gabriele Gentschew and Peter Reitz. These partnerships enhance the development and implementation of his innovative ideas.

Conclusion

Wolfgang Stille's contributions to the field of implantable active substance depot materials exemplify the impact of innovation in medical technology. His work not only showcases his inventive spirit but also holds promise for improving patient treatment options in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…